The operational realities of CAR-T cell therapies

Monday, August 3, 2026

BlueskyReddit

CAR-T cell therapy has achieved what once seemed impossible — genetically reprogramming a patient's own immune cells to hunt down and destroy cancer. But as the science races forward, the realities of bringing these living medicines to patients grow more complex.

This eBook examines CAR-T cell therapy through the lens of the people and organizations at the forefront of its development. Readers will gain insights into:

  • How sponsors and clinical sites are managing the operational complexity of CAR-T trials
  • The field's expansion into autoimmune disease
  • The current state of CAR-T manufacturing
  • Strategies for optimizing manufacturing processes to improve scalability and affordability
  • How developers are navigating the risks and challenges that define the modality

Access Now

    Please fill out the information below to access the selected content. If you are already registered, and this information will be filled out for you.

  • Please enter your first and last name.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • By submitting this form, you consent to Cell & Gene Therapy Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.